Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

about

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients.

P2860

Q54986297-971C2AC9-645D-412C-A0CF-176BF415CAB3

P2860

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

Item

http://www.wikidata.org/entity/Q40141235

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Stereotactic body radiation vs ...... nresectable pancreatic cancer.

@en

type

Item

label

Stereotactic body radiation vs ...... nresectable pancreatic cancer.

@en

prefLabel

Stereotactic body radiation vs ...... nresectable pancreatic cancer.

@en

P1476

Stereotactic body radiation vs ...... unresectable pancreatic cancer

@en

P2093

Abraham J Wu

http://www.w3.org/2001/XMLSchema#string

Carla Hajj

http://www.w3.org/2001/XMLSchema#string

Christopher H Crane

http://www.w3.org/2001/XMLSchema#string

John J Cuaron

http://www.w3.org/2001/XMLSchema#string

Karyn A Goodman

http://www.w3.org/2001/XMLSchema#string

Kenneth H Yu

http://www.w3.org/2001/XMLSchema#string

Marsha Reyngold

http://www.w3.org/2001/XMLSchema#string

Weiji Shi

http://www.w3.org/2001/XMLSchema#string

Zhigang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.

Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.

Treatment of locally advanced pancreatic cancer: the role of radiation therapy.

Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.

Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.

P304

1746-1753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1342863

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maeve Lowery

Eileen M O'Reilly

Joseph J Park

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28661823

http://www.w3.org/2001/XMLSchema#string

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

about

P2860

P2860

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698